» Articles » PMID: 31460500

Microvascular Obstruction in Acute Myocardial Infarction: an Old and Unsolved Mystery

Overview
Journal Med Pharm Rep
Specialty General Medicine
Date 2019 Aug 29
PMID 31460500
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In the setting of acute myocardial infarction, flow restoration in the culprit epicardial coronary artery is not synonymous with efficient reperfusion. Microvascular obstruction occurs in 50% of cases and represents a predictor of a long-term unfavorable outcome. Its prevalence has remained constant in recent years despite various treatment attempts. However, the success of targeted therapies could be mainly a problem of timing. Recent data bring evidence with regard to the role of pre-procedural distal embolization and highlight the relation between distal embolism, microvascular obstruction and intramyocardial inflammation. As a result, early detection of microvascular injury represents the first step in the development of targeted, individualized therapeutic approaches. In this context, the identification of new invasive surrogate parameters for the timely assessment and quantification of microvascular obstruction in the catheterization laboratory has become an important subject of current research. Among these, coronary wedge pressure is the most practical and revealing in the setting of primary percutaneous coronary intervention. It may offer comprehensive details on the mechanisms of microvascular injury and may therefore offer guidance for appropriate treatment selection.

Citing Articles

Angiogenesis after acute myocardial infarction: a bibliometric -based literature review.

Tan Y, Li M, Ma X, Shi D, Liu W Front Cardiovasc Med. 2025; 12:1426583.

PMID: 40017521 PMC: 11865093. DOI: 10.3389/fcvm.2025.1426583.


Culprit-Lesion Drug-Coated-Balloon Percutaneous Coronary Intervention in Patients Presenting with ST-Elevation Myocardial Infarction (STEMI).

Sanz-Sanchez J, Teira Calderon A, Neves D, Cortes Villar C, Lukic A, Rumiz Gonzalez E J Clin Med. 2025; 14(3).

PMID: 39941540 PMC: 11818855. DOI: 10.3390/jcm14030869.


Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial.

Khani E, Aslanabadi N, Mehravani K, Rezaei H, Afsharirad H, Entezari-Maleki T Am J Cardiovasc Drugs. 2024; 24(5):673-684.

PMID: 38969953 DOI: 10.1007/s40256-024-00662-4.


Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction.

Khattak S, Townend J, Thomas M Front Mol Biosci. 2024; 11:1287553.

PMID: 38545417 PMC: 10965715. DOI: 10.3389/fmolb.2024.1287553.


T and Small Protrusion (TAP) Technique in Bifurcations: Coronary Artery Disease in Acute Myocardial Infarction Patients after COVID-19 Pneumonia.

Rus M, Filimon G, Ardelean A Biomedicines. 2023; 11(8).

PMID: 37626751 PMC: 10452908. DOI: 10.3390/biomedicines11082255.


References
1.
Welt F, Rogers S, Zhang X, Ehlers R, Chen Z, Nannizzi-Alaimo L . GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention. Catheter Cardiovasc Interv. 2004; 61(2):185-9. DOI: 10.1002/ccd.10763. View

2.
Bellandi F, Maioli M, Gallopin M, Toso A, Dabizzi R . Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention. Catheter Cardiovasc Interv. 2004; 62(2):186-92. DOI: 10.1002/ccd.20041. View

3.
Furman M, Krueger L, Linden M, Fox M, Ball S, Barnard M . GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention. J Thromb Haemost. 2005; 3(2):312-20. DOI: 10.1111/j.1538-7836.2005.01124.x. View

4.
Sorajja P, Gersh B, Costantini C, McLaughlin M, Zimetbaum P, Cox D . Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. Eur Heart J. 2005; 26(7):667-74. DOI: 10.1093/eurheartj/ehi167. View

5.
Stone G, Webb J, Cox D, Brodie B, Qureshi M, Kalynych A . Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005; 293(9):1063-72. DOI: 10.1001/jama.293.9.1063. View